Diabetes associated with antiretroviral treatment initiation
DOI:
https://doi.org/10.32818/reccmi.a3s1a7Keywords:
diabetes mellitus , protease inhibitors, HIV infectionAbstract
The rise in life expectancy in HIV patients due to medical advances in antiretroviral therapy highlights the importance of chronic comorbidities and cardiovascular risk management in these patients. After their development, first Protease Inhibitors were related to metabolic adverse effects, including hyperglycemia. We present a case of a patient who developed new-onset Diabetes mellitus associated with the initiation of antiretroviral therapy with these drugs.
Downloads
Metrics
References
Spollett GR, MSN, ANP, CDE. Hyperglycemia in HIV/AIDS. Diabetes Spectrum. 2006 Jul; 19(3): 163-166.
Tsiodras S, Mantzoros C, Hammer S, Samore M. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med. 2000 Jul 10; 160(13): 2050-2056.
D’Ettorre G, Ceccarelli G, Zaccarelli M, Ascoli-Bartoli T, Bianchi L, Bellelli V, et al. Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: the ATAzanavir & GLUcose metabolism (ATAGLU) study. Int J STD AIDS. 2016 Jul; 27(8): 638-643.
Kalra S, Kalra B, Agrawal N, Unnikrishnan AG. Understanding diabetes in patients with HIV/AIDS. Diabetology & Metabolic Syndrome. 2011; 3: 2.
Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, et al. Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens. Diabetes. 2003 Apr; 52(4): 918-925.
Murata H, Hruz PW, Mueckler M. Indinavir inhibits the glucose transporter isoform GLUT 4 at physiologic concentrations. AIDS. 2002 Apr 12; 16(6): 859-863.
Rehman A, Setter SM, Vue MH. Drug-Induced Glucose Alterations Part 2: Drug-Induced Hyperglycemia. PharmD Diabetes Spectrum. 2011 Nov; 24(4): 234-238.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Carlos Tarrazo-Tarrazo, José Javier Garrido-Sánchez, Jaime Casal-Álvarez, Diego Eduardo Olivo-Aguilar, Víctor Arenas-García
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
